Abstract

Inferior vena cava filters (IVCF) have increasingly been used for prevention of pulmonary thromboembolism (PTE) in deep venous thrombosis (DVP) when anticoagulant therapy is contraindicated or in patients presumed to be at high risk. Persistent DVP and risk factors or lack of follow-up may account

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.